Cutera Obtains Japanese Regulatory Clearance for enlighten™
March 31 2016 - 8:00AM
enlighten is the first and only
picosecond laser granted clearance by Japan’s
Ministry of Health, Labour and Welfare
Cutera, Inc. (NASDAQ:CUTR) (“Cutera” or the “Company”), a leading
provider of laser and energy-based aesthetic systems for
practitioners worldwide, announced today that Japan’s medical
device regulatory authority, the Ministry of Health, Labour and
Welfare, granted regulatory clearance for its enlightenTM
picosecond laser platform.
“We are pleased to be first to market in Japan
with a clearance for our enlighten platform for the treatment of
benign pigmented lesions, which is the most popular application for
enlighten in Asia. As we look forward with our plans for this
enabling-technology platform, obtaining additional international
clearances for enlighten is one of the key components of our
international strategy. As such, the Japanese clearance is the
latest addition to our growing list of country-specific approvals,”
said Kevin Connors, President and CEO of Cutera, Inc.
About Cutera, Inc. Brisbane,
California-based Cutera is a leading provider of laser and other
energy-based aesthetic systems for practitioners worldwide. Since
1998, Cutera has been developing innovative, easy-to-use products
that enable physicians and other qualified practitioners to offer
safe and effective aesthetic treatments to their patients. For more
information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking
statements within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Specifically, statements concerning
Cutera's ability to obtain additional clearances for enlighten,
increase revenue, and statements regarding long-term prospects and
opportunities in the laser and other energy-based equipment
aesthetic market are forward-looking statements within the meaning
of the Safe Harbor. Forward-looking statements are based on
management's current, preliminary expectations and are subject to
risks and uncertainties, which may cause Cutera's actual results to
differ materially from the statements contained herein. Potential
risks and uncertainties that could affect Cutera's business and
cause its financial results to differ materially from those
contained in the forward-looking statements include the
Company’s ability to successfully develop and launch new products
and applications and market them to both its installed base and new
customers; unforeseen events and circumstances relating to the
Company’s operations; government regulatory actions; and those
other factors described in the section entitled, “Risk Factors” in
its most recent Form 10-K as filed with the Securities and Exchange
Commission on March 15th, 2016. Undue reliance should not be
placed on forward-looking statements, which speak only as of the
date they are made. Cutera undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date they were made, or to
reflect the occurrence of unanticipated events.
CONTACTS:
Cutera, Inc.
Ron Santilli
Chief Financial Officer
415-657-5500
Investor Relations
John Mills
Integrated Corporate Relations, Inc.
646-277-1254
john.mills@icrinc.com
Cutera (NASDAQ:CUTR)
Historical Stock Chart
From Sep 2024 to Oct 2024
Cutera (NASDAQ:CUTR)
Historical Stock Chart
From Oct 2023 to Oct 2024